InsiderTrades.com logo

MBX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $20,600,619.31
Insider Selling (Last 12 Months): $0.00

MBX Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at MBX Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MBX Biosciences Share Price & Price History

Current Price: $9.62
Price Change: ▲ Price Increase of +0.625 (6.95%)
As of 04/24/2025 04:26 PM ET

This chart shows the closing price history over time for MBX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

MBX Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/8/2025Ora H PescovitzDirectorBuy7,693$5.89$45,311.7724,329View SEC Filing Icon  
2/18/2025Carl L GordonDirectorBuy143,170$10.84$1,551,962.803,255,000View SEC Filing Icon  
2/14/2025Carl L GordonDirectorBuy47,502$9.87$468,844.743,205,930View SEC Filing Icon  
2/4/2025P. Kent HawrylukCEOBuy50,000$10.69$534,500.00448,277View SEC Filing Icon  
9/16/2024Edward T MathersDirectorBuy500,000$16.00$8,000,000.003,614,486View SEC Filing Icon  
9/16/2024Life Sciences X L.P. FrazierMajor ShareholderBuy625,000$16.00$10,000,000.004,552,774View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for MBX Biosciences (NYSE:MBX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MBX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MBX Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/24/2025Wellington Management Group LLP2,909,639$52.99M0.0%-1.0%8.705%Search for SEC Filing on Google Icon
2/17/2025Woodline Partners LP608,721$11.22M0.1%+17.1%1.821%Search for SEC Filing on Google Icon
2/17/2025Parkman Healthcare Partners LLC170,000$3.13M0.4%N/A0.509%Search for SEC Filing on Google Icon
2/17/2025Nuveen Asset Management LLC14,471$0.27M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC333,642$6.15M0.0%-24.2%0.998%Search for SEC Filing on Google Icon
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,335$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG4,338$80K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/17/2025Driehaus Capital Management LLC1,581,760$29.15M0.2%+61.2%4.733%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC220,330$4.06M0.0%+62.5%0.659%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE16,059$0.30M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets1,486$27K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/17/2025Alyeska Investment Group L.P.174,700$3.22M0.0%-22.4%0.523%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC71,500$1.32M0.0%N/A0.214%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp90,682$1.67M0.0%N/A0.271%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company 49,675$0.92M0.0%+7.5%0.149%Search for SEC Filing on Google Icon
2/14/2025Virtus ETF Advisers LLC3,468$64K0.0%N/A0.010%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD1,161,527$21.41M0.0%-2.6%3.476%Search for SEC Filing on Google Icon
2/14/2025MetLife Investment Management LLC7,230$0.13M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP25,900$0.48M0.0%+115.8%0.077%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN5,844$0.11M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC265,703$4.90M0.0%+1,093.2%0.795%Search for SEC Filing on Google Icon
2/12/2025Franklin Resources Inc.369,300$6.81M0.0%-17.9%1.105%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP2,909,639$52.99M0.0%-1.0%8.706%Search for SEC Filing on Google Icon
2/12/2025Norges Bank25,000$0.46M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/12/2025BIT Capital GmbH12,743$0.24M0.0%N/A0.038%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.9,106$0.17M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.5,593$0.10M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/11/2025Platinum Investment Management Ltd.162,090$2.99M0.2%+8.1%0.485%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.93,311$1.72M0.0%N/A0.279%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp23,914$0.44M0.0%N/A0.072%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers9,472$0.18M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.450,000$11.69M0.0%N/A1.347%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC16,400$0.43M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/18/2024Teachers Retirement System of The State of Kentucky26,708$0.69M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC22,269$0.58M0.0%N/A0.067%Search for SEC Filing on Google Icon
11/15/2024Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC16,400$0.43M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC26,570$0.69M0.0%N/A0.080%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791%Search for SEC Filing on Google Icon
11/15/2024Soros Fund Management LLC30,000$0.78M0.0%N/A0.090%Search for SEC Filing on Google Icon
11/15/2024RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd24,011$0.62M0.0%N/A0.072%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.15,600$0.41M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/15/2024Maven Securities LTD50,000$1.30M0.0%N/A0.150%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.10,706$0.28M0.1%N/A0.032%Search for SEC Filing on Google Icon
11/14/2024NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company46,194$1.20M0.0%N/A0.138%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MBX Biosciences logo
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.
Read More on MBX Biosciences

Today's Range

Now: $9.62
Low: $8.92
High: $9.77

50 Day Range

MA: $8.46
Low: $5.79
High: $11.83

52 Week Range

Now: $9.62
Low: $4.81
High: $27.50

Volume

172,645 shs

Average Volume

249,373 shs

Market Capitalization

$321.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of MBX Biosciences?

MBX Biosciences' top insider shareholders include:
  1. Life Sciences X LP Frazier (Major Shareholder)
  2. Edward T Mathers (Director)
  3. Carl L Gordon (Director)
  4. P Kent Hawryluk (CEO)
  5. Ora H Pescovitz (Director)
Learn More about top insider investors at MBX Biosciences.